0 CHECKOUT

Summary: Fishers Redevelopment Authority, Indiana Fishers; General Obligation; General Obligation Equivalent Security Jun 11

  • ID: 1826857
  • June 2011
  • Region: Indiana
  • Standard & Poors

FEATURED COMPANIES

  • Fishers
  • Fishers Redev Auth
  • Fishers Twn Redev Dist
  • MORE

Abstract
Standard & Poor's Ratings Services has assigned its 'AA' long-term rating and stable outlook to Fishers Redevelopment Authority, Ind.'s lease rental revenue bonds of 2011 and affirmed its 'AA' long-term rating and underlying rating (SPUR) on Fishers' existing general obligation (GO) and GO equivalent bonds, reflecting our view of the town's: Participation in the diverse Indianapolis metropolitan area economy, which continues to contribute toward tax base and population growth; Healthy and diverse local economy, coupled with low unemployment; Very strong income and extremely strong wealth levels; and Good financial management practices that support a very strong financial position. We consider the town's moderate-to-high debt burden and elevated debt service carrying charges, a result of the capital pressures that coincide with...

Companies mentioned in this report are:
- Fishers
- Fishers Twn Hall Bldg Corp
- Fishers Redev Auth
- Fishers Twn Redev Dist

Action: Affirmed
Action: New Rating
Action: Outlook: Stable

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, READ MORE >

Note: Product cover images may vary from those shown

- Fishers
- Fishers Twn Hall Bldg Corp
- Fishers Redev Auth
- Fishers Twn Redev Dist

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: This Credit Rating Report will be emailed to you.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS

Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer, Inc.